Literature DB >> 28062559

ATRX and DAXX: Mechanisms and Mutations.

Michael A Dyer1, Zulekha A Qadeer2,3, David Valle-Garcia2, Emily Bernstein2,3.   

Abstract

Recent genome sequencing efforts in a variety of cancers have revealed mutations and/or structural alterations in ATRX and DAXX, which together encode a complex that deposits histone variant H3.3 into repetitive heterochromatin. These regions include retrotransposons, pericentric heterochromatin, and telomeres, the latter of which show deregulation in ATRX/DAXX-mutant tumors. Interestingly, ATRX and DAXX mutations are often found in pediatric tumors, suggesting a particular developmental context in which these mutations drive disease. Here we review the functions of ATRX and DAXX in chromatin regulation as well as their potential contributions to tumorigenesis. We place emphasis on the chromatin remodeler ATRX, which is mutated in the developmental disorder for which it is named, α-thalassemia, mental retardation, X-linked syndrome, and at high frequency in a number of adult and pediatric tumors.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28062559      PMCID: PMC5334245          DOI: 10.1101/cshperspect.a026567

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  51 in total

Review 1.  Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.

Authors:  Srinivasan Yegnasubramanian; Angelo M De Marzo; William G Nelson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

Review 2.  Mutant ATRX: uncovering a new therapeutic target for glioma.

Authors:  Santiago Haase; María Belén Garcia-Fabiani; Stephen Carney; David Altshuler; Felipe J Núñez; Flor M Méndez; Fernando Núñez; Pedro R Lowenstein; Maria G Castro
Journal:  Expert Opin Ther Targets       Date:  2018-06-20       Impact factor: 6.902

Review 3.  Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease.

Authors:  Flor M Mendez; Felipe J Núñez; Maria B Garcia-Fabiani; Santiago Haase; Stephen Carney; Jessica C Gauss; Oren J Becher; Pedro R Lowenstein; Maria G Castro
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

Review 4.  Solid tumours hijack the histone variant network.

Authors:  Flávia G Ghiraldini; Dan Filipescu; Emily Bernstein
Journal:  Nat Rev Cancer       Date:  2021-02-10       Impact factor: 60.716

5.  Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.

Authors:  Christian P Bradley; Cai Chen; Karolyn A Oetjen; Cheng Yan; Reema Panjwani; Sara Hauffe; Katherine R Calvo; Constance Yuan; Prapti Arvind Patel; Nathan D Montgomery; Matthew C Foster; Minoo Battiwalla; A John Barrett; Richard J Gibbons; Sawa Ito
Journal:  Blood Adv       Date:  2019-09-10

6.  H3.3 Nucleosome Assembly Mutants Display a Late-Onset Maternal Effect.

Authors:  Kirk B Burkhart; Steven R Sando; Anna Corrionero; H Robert Horvitz
Journal:  Curr Biol       Date:  2020-05-28       Impact factor: 10.834

7.  Proteome-wide mapping of short-lived proteins in human cells.

Authors:  Jiaming Li; Zhenying Cai; Laura Pontano Vaites; Ning Shen; Dylan C Mitchell; Edward L Huttlin; Joao A Paulo; Brian L Harry; Steven P Gygi
Journal:  Mol Cell       Date:  2021-10-08       Impact factor: 17.970

8.  Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.

Authors:  Timothy L Lochmann; Krista M Powell; Jungoh Ham; Konstantinos V Floros; Daniel A R Heisey; Richard I J Kurupi; Marissa L Calbert; Maninderjit S Ghotra; Patricia Greninger; Mikhail Dozmorov; Madhu Gowda; Andrew J Souers; C Patrick Reynolds; Cyril H Benes; Anthony C Faber
Journal:  Sci Transl Med       Date:  2018-05-16       Impact factor: 17.956

Review 9.  Chromatin regulation and dynamics in stem cells.

Authors:  David C Klein; Sarah J Hainer
Journal:  Curr Top Dev Biol       Date:  2019-12-30       Impact factor: 4.897

10.  ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.

Authors:  Zulekha A Qadeer; David Valle-Garcia; Dan Hasson; Zhen Sun; April Cook; Christie Nguyen; Aroa Soriano; Anqi Ma; Lyra M Griffiths; Maged Zeineldin; Dan Filipescu; Luz Jubierre; Asif Chowdhury; Orla Deevy; Xiang Chen; David B Finkelstein; Armita Bahrami; Elizabeth Stewart; Sara Federico; Soledad Gallego; Fumiko Dekio; Mary Fowkes; David Meni; John M Maris; William A Weiss; Stephen S Roberts; Nai-Kong V Cheung; Jian Jin; Miguel F Segura; Michael A Dyer; Emily Bernstein
Journal:  Cancer Cell       Date:  2019-10-17       Impact factor: 38.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.